In March 2020, while most people around the world were working or studying from home as the COVID-19 pandemic shut down communities, City of Hope scientist Don J. Diamond...

A triple threat of COVID-19, influenza (flu) and respiratory syncytial virus (RSV) is hitting our communities hard. RSV rates continue to climb in Southern California, and we still are battling...

CONTACTLetisia [email protected] killer (NK) cells engineered with chimeric antigen receptor (CAR) cells to better fight COVID-19 LOS ANGELES  — City of Hope researchers have engineered an...

National Hospital Week is an opportunity to highlight hospitals, health systems and health care workers and the innovative ways they are supporting and connected to patients and the community. As...

Emile Auguste Jr., a 64-year-old mortgage banker from Monrovia, California, has no qualms about maintaining his regular colorectal cancer screenings in the current COVID-19-altered environment.   “Concerns? Not for me!”...

  Don J. Diamond, Ph.D. COH04S1, a City of Hope-developed COVID-19 investigational vaccine, stimulated broad-spectrum protective immunity against SARS-CoV-2 variants in new preclinical research due to its inclusion of both...

Raynald Samoa, M.D., gets emotional when he remembers what his grandmother would tell him. “She’d say, ‘I wrap my love for you in your shadow,’ meaning her love would...

A COVID-19 investigational vaccine developed by City of Hope scientists and now licensed to GeoVax Labs Inc. produced a robust neutralizing antibody and T cell (an immune cell) response against...

Recently, the Centers for Disease Control and Prevention (CDC) released their recommendation that certain immunocompromised people receive a supplemental dose of the COVID-19 vaccine — a “booster.” Here, we provide...

MEDIA CONTACTLetisia [email protected] The investigational vaccine is now being used in Phase 2 trials for immunocompromised patients and as a booster for healthy adult volunteers. ...